Howard Kaufman, MD - Episode 3

Emerging Checkpoint Inhibitors and Therapeutic Oncolytic Viruses

EP. 1: The Evolution of Immunotherapy in Cancer
EP. 2: Patient Selection for Checkpoint Inhibitor Therapy and Assessing Response
Now Viewing
EP. 3: Emerging Checkpoint Inhibitors and Therapeutic Oncolytic Viruses
EP. 4: Adoptive T-Cell Approaches and Tumor Vaccine Strategies
EP. 5: The Future and the Era of Precision Immunology
EP. 6: Managing Avelumab Side Effects in Patients With Merkel Cell Carcinoma
EP. 7: Emerging Agents in the Pipeline for Merkel Cell Carcinoma
EP. 8: Role of Immunotherapy in Merkel Cell Carcinoma